1.Complete remission of maxillary and infratemporal squamous cellcarcinoma after induction chemotherapy.
Jong Ryoul KIM ; One Ryong MOON ; Sang Jun PARK ; Uk Kyu KIM ; Dong Kyu YANG
Journal of the Korean Association of Oral and Maxillofacial Surgeons 1992;18(1):91-97
No abstract available.
Induction Chemotherapy*
2.The role of combined induction chemotherapy and radical radiation therapy in the treatment of advanced nasopharyngeal cancer.
Jin Hyuk CHOI ; Jae Kyung ROH ; Ho Young LIM ; Hyun Chul JUNG ; Nae Choon YOO ; Shin Ki AHN ; Eun Hee KOH ; Joo Hang KIM ; Chang Ok SEO ; Kwi Un KIM ; Joon Kyoo ROH ; Byung Soo KIM
Journal of the Korean Cancer Association 1993;25(3):403-416
No abstract available.
Induction Chemotherapy*
;
Nasopharyngeal Neoplasms*
3.Effect of induction chemotherapy in advanced epithelial ovarian cancer.
Tchan Kyu PARK ; Hyung Min CHOI ; Soo Nyung KIM ; Hyeong Soon KIM ; Gyung Soo KIM ; Jeong Yeon KIM
Journal of the Korean Cancer Association 1992;24(5):724-729
No abstract available.
Induction Chemotherapy*
;
Ovarian Neoplasms*
4.The Long-term Effect of Induction Chemotherapy with All-trans-retinoic Acid(ATRA) Follwed by Consolidation Chemotherapy for Newly Diagnosed Acute Promyelocytic Leukemia.
Joo Young JEONG ; Hark Kyun KIM ; Soo Mi BANG ; Young Jin YOO ; Muhn Hee LEE ; Jin Seok AHN ; Jong Tae LEE ; Seok Ah LIM ; Seon Yang PARK ; Byoung Kook KIM ; Noe Kyeong KIM
Korean Journal of Hematology 1999;34(1):80-89
No abstract available.
Consolidation Chemotherapy*
;
Induction Chemotherapy*
;
Leukemia, Promyelocytic, Acute*
5.Induction chemotherapy in locally advanced cervical cancer.
Yong Hak KIM ; Byung Gyu YOO ; Ki Tae KIM ; Hyun Chan KIM
Korean Journal of Obstetrics and Gynecology 1992;35(9):1288-1299
No abstract available.
Induction Chemotherapy*
;
Uterine Cervical Neoplasms*
6.Induction chemotherapy in the treatment of locally advanced breast cancer.
Sam Gee CHOI ; You Sah KIM ; Joong Shin KANG
Journal of the Korean Surgical Society 1992;42(1):21-29
No abstract available.
Breast Neoplasms*
;
Breast*
;
Induction Chemotherapy*
7.The effects of induction chemotherapy in the management of ultra high-risk gestational trophoblastic neoplasia.
Agnes L. Soriano-Estrella ; Koleen C. Pasamba
Acta Medica Philippina 2024;58(11):22-28
Objectives:
This study aimed to determine the clinical outcomes of ultra high-risk gestational trophoblastic neoplasia (GTN) patients managed with and without induction chemotherapy in the Division of Trophoblastic Diseases, Department of Obstetrics and Gynecology, Philippine General Hospital.
Methods:
Clinical and demographic data were collected retrospectively from ultra high-risk GTN patients admitted in the Division of Trophoblastic Diseases, Department of Obstetrics and Gynecology, Philippine General Hospital from January 2015 to December 2021. Rate of remission and early death of those who received induction chemotherapy were compared to those who did not.
Results:
A total of 21 patients with ultra high-risk GTN were included in the study, nine of whom underwent induction chemotherapy while 12 had no induction chemotherapy and was given the standard EMACO regimen. There was no significant difference in the rate of early death as well as the rate and time to achieve remission between those who received induction chemotherapy compared to those who were immediately started on EMACO.
Conclusion
A firm conclusion cannot be drawn from the results considering the small population included in the study. Further studies with larger sample size and prospective study design are recommended.
Induction Chemotherapy
;
Gestational Trophoblastic Disease
8.Effects of Induction Chemotherapy with BHAC Plus Idarubicin on Long-term Survival for Patients with Acute Myelogenous Leukemia according to Different Postremission Strategies.
Chun Choo KIM ; Jong Wook LEE ; Hee Je KIM ; Ki Won KIM ; Soo Jeong PARK ; Jung Gon SUH ; Chang Ki MIN ; Hyeon Seok EOM ; Young Seon HONG ; Woo Sung MIN ; Wan Shik SHIN ; Dong Jip KIM
Korean Journal of Hematology 1999;34(2):317-325
No abstract available.
Humans
;
Idarubicin*
;
Induction Chemotherapy*
;
Leukemia, Myeloid, Acute*
9.Walk-Up flap for Reconstruction of Oral and Maxillofacial defects
Sang Hun SHIN ; Sung Jin PARK ; Kwang Ho LEE ; Sung Keun LEE
Journal of the Korean Association of Maxillofacial Plastic and Reconstructive Surgeons 2000;22(2):249-253
induction chemotherapy, tongue S.C.C. is excised surgically and reconstructed by use of PMMC flap. Post-op infection results in surrounding soft tissue defect with oro-facial fistula. We have experienced a case of Walk-up flap by use of PMMC flap for reconstruction with satisfactory result, so we report it with literature reviews.]]>
Deglutition
;
Fistula
;
Induction Chemotherapy
;
Mastication
;
Tongue
10.Less is more: role of additional chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal cancer management
Radiation Oncology Journal 2019;37(2):67-72
Concurrent chemoradiation therapy (CCRT) has played the most important and central role in the definitive therapy for the patients with locoregionally advanced stage nasopharynx cancer. The addition of induction chemotherapy (IC) or adjuvant chemotherapy (AC) to CCRT have been widely accepted with the rationale of improving distant control in the clinical practices. This review article investigated the role of IC and AC based on 11 recent meta-analysis publications, and found that the clinical benefits obtained by the additional IC or AC to CCRT, at the cost of the increased risks of more frequent and more severe side effects, seemed not big enough. More intervention is not always better, however, less seems frequently good enough. The author would speculate that ‘less is more’ and would advocate CCRT alone as the current standard.
Chemoradiotherapy
;
Chemotherapy, Adjuvant
;
Drug Therapy
;
Humans
;
Induction Chemotherapy
;
Nasopharyngeal Neoplasms
Result Analysis
Print
Save
E-mail